ROSENDALE MARTIN P 4
4 · CYTOMEDIX INC · Filed Jul 18, 2011
Insider Transaction Report
Form 4
CYTOMEDIX INCCMXI
ROSENDALE MARTIN P
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Other
Common Stock
2011-07-15+1,250→ 93,073 total
Footnotes (1)
- [F1]Received pursuant to a stock dividend as the Company's outstanding Series D Convertible Preferred Stock.